Checkerspot

Biotechnology · Alameda, CA · Founded 2016 · Privately Held (backing)

Developer of a biotechnology platform intended to engineer fats and oils through precision fermentation to create functional lipids that support nutritional needs across all life stages. Checkerspot is based in Alameda, CA and was founded in 2016. Its last reported valuation was $347 million in Sep 2022. It has raised $157 million across 5 recorded rounds; the latest was a $7.6 million early-stage round in Nov 2025.

Last reported valuation
$347.0M
Oct 2026
Priced at
—
Total raised
$157.0M
Last round
Early Stage VC
Nov 2025
What is Checkerspot worth?
$347.0Mlast reported valuation · Oct 2026

Checkerspot's last reported valuation, Sep 2022. Nothing priced has surfaced since.

Free account
More of Checkerspot with a free account
  • ·The complete investor list: 19 names
  • ·Watch Checkerspot: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Checkerspot funding history

5 rounds
DateRoundRaisedPost-money
Nov 2025Early Stage VC$7.6M▮
Sep 2022Early Stage VC$40.0M▮
Aug 2020Early Stage VC (Series B)$36.0M▮
Apr 2019Early Stage VC (Series A)$13.0M▮
May 2018Seed Round$5.4M▮
Unlock post-money valuations

Membership and data by Private Market View

Checkerspot valuation

Checkerspot's last reported valuation was $347 million in Sep 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Checkerspot raised?

Checkerspot has raised $157 million across 5 recorded rounds since 2018. The largest was a $7.6 million early-stage round in Nov 2025.

Checkerspot has filed 4 Form Ds with the SEC since 2018, most recently in Dec 2025 ($7.6 million sold to 6 investors).

Comparable companies

Comparable biotechnology names by valuation on PrivateMarketView: CellCentric ($382 million), Ansa Biotechnologies ($269 million) and Ambros Therapeutics ($250 million).

How Checkerspot's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Checkerspot, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Checkerspot

What is Checkerspot worth?
Checkerspot is valued at $347.0M as of Oct 2026. Checkerspot's last reported valuation, Sep 2022. Nothing priced has surfaced since.
How much has Checkerspot raised?
Checkerspot has raised $157.0M in total funding across 5 recorded rounds.
When did Checkerspot last raise?
Checkerspot last raised in Nov 2025 (Early Stage VC), raising $7.6M.